Annual Revenue
$127.04 M
+$19.37 M+17.99%
31 December 2023
Summary:
Heron Therapeutics annual revenue is currently $127.04 million, with the most recent change of +$19.37 million (+17.99%) on 31 December 2023. During the last 3 years, it has risen by +$38.41 million (+43.33%). HRTX annual revenue is now -12.96% below its all-time high of $145.97 million, reached on 31 December 2019.HRTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$32.81 M
-$3.21 M-8.92%
30 September 2024
Summary:
Heron Therapeutics quarterly revenue is currently $32.81 million, with the most recent change of -$3.21 million (-8.92%) on 30 September 2024. Over the past year, it has increased by +$1.38 million (+4.38%). HRTX quarterly revenue is now -23.02% below its all-time high of $42.62 million, reached on 30 September 2019.HRTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$137.74 M
+$1.38 M+1.01%
30 September 2024
Summary:
Heron Therapeutics TTM revenue is currently $137.74 million, with the most recent change of +$1.38 million (+1.01%) on 30 September 2024. Over the past year, it has increased by +$14.90 million (+12.13%). HRTX TTM revenue is now -5.64% below its all-time high of $145.97 million, reached on 31 December 2019.HRTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.0% | +4.4% | +12.1% |
| 3 y3 years | +43.3% | +41.2% | +59.6% |
| 5 y5 years | +64.0% | -23.0% | -1.4% |
HRTX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +47.1% | -8.9% | +58.9% | at high | +59.6% |
| 5 y | 5 years | -13.0% | +64.0% | -23.0% | +64.3% | -5.6% | +65.9% |
| alltime | all time | -13.0% | >+9999.0% | -23.0% | +597.1% | -5.6% | >+9999.0% |
Heron Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $32.81 M(-8.9%) | $137.74 M(+1.0%) |
| June 2024 | - | $36.02 M(+3.9%) | $136.36 M(+3.2%) |
| Mar 2024 | - | $34.67 M(+1.3%) | $132.10 M(+4.0%) |
| Dec 2023 | $127.04 M(+18.0%) | $34.23 M(+8.9%) | $127.04 M(+3.4%) |
| Sept 2023 | - | $31.43 M(-1.0%) | $122.84 M(+4.1%) |
| June 2023 | - | $31.76 M(+7.2%) | $117.96 M(+3.6%) |
| Mar 2023 | - | $29.61 M(-1.4%) | $113.83 M(+5.7%) |
| Dec 2022 | $107.67 M(+24.7%) | $30.03 M(+13.1%) | $107.67 M(+9.5%) |
| Sept 2022 | - | $26.56 M(-3.9%) | $98.30 M(+3.5%) |
| June 2022 | - | $27.63 M(+17.8%) | $94.97 M(+5.8%) |
| Mar 2022 | - | $23.46 M(+13.6%) | $89.78 M(+4.0%) |
| Dec 2021 | $86.35 M(-2.6%) | $20.66 M(-11.1%) | $86.35 M(+0.1%) |
| Sept 2021 | - | $23.23 M(+3.5%) | $86.30 M(+3.9%) |
| June 2021 | - | $22.44 M(+12.1%) | $83.03 M(-0.3%) |
| Mar 2021 | - | $20.02 M(-2.8%) | $83.26 M(-6.1%) |
| Dec 2020 | $88.64 M(-39.3%) | $20.61 M(+3.2%) | $88.64 M(-14.0%) |
| Sept 2020 | - | $19.96 M(-11.9%) | $103.12 M(-18.0%) |
| June 2020 | - | $22.67 M(-10.8%) | $125.78 M(-10.0%) |
| Mar 2020 | - | $25.40 M(-27.6%) | $139.77 M(-4.2%) |
| Dec 2019 | $145.97 M(+88.4%) | $35.08 M(-17.7%) | $145.97 M(+4.5%) |
| Sept 2019 | - | $42.62 M(+16.3%) | $139.73 M(+19.5%) |
| June 2019 | - | $36.66 M(+16.0%) | $116.89 M(+19.9%) |
| Mar 2019 | - | $31.60 M(+9.6%) | $97.51 M(+25.9%) |
| Dec 2018 | $77.47 M(+151.8%) | $28.84 M(+45.8%) | $77.47 M(+32.0%) |
| Sept 2018 | - | $19.79 M(+14.5%) | $58.68 M(+23.6%) |
| June 2018 | - | $17.28 M(+49.4%) | $47.47 M(+22.7%) |
| Mar 2018 | - | $11.57 M(+15.1%) | $38.70 M(+25.8%) |
| Dec 2017 | $30.77 M(+2305.6%) | $10.05 M(+17.3%) | $30.77 M(+39.9%) |
| Sept 2017 | - | $8.57 M(+0.7%) | $21.99 M(+63.9%) |
| June 2017 | - | $8.51 M(+134.3%) | $13.42 M(+173.3%) |
| Mar 2017 | - | $3.63 M(+184.0%) | $4.91 M(+284.0%) |
| Dec 2016 | $1.28 M(+98.0%) | $1.28 M(+409.6%) | $1.28 M(+8.8%) |
| Dec 2011 | $646.00 K(-50.3%) | - | - |
| June 2011 | - | $251.00 K(-36.5%) | $1.18 M(-19.2%) |
| Mar 2011 | - | $395.00 K(+120.7%) | $1.46 M(+11.8%) |
| Dec 2010 | $1.30 M(+3.2%) | $179.00 K(-49.0%) | $1.30 M(+4.6%) |
| Sept 2010 | - | $351.00 K(-33.8%) | $1.24 M(-38.1%) |
| June 2010 | - | $530.00 K(+119.9%) | $2.01 M(+34.5%) |
| Mar 2010 | - | $241.00 K(+97.5%) | $1.49 M(+18.5%) |
| Dec 2009 | $1.26 M(+241.7%) | $122.00 K(-89.1%) | $1.26 M(+8.7%) |
| Sept 2009 | - | $1.12 M(+7878.6%) | $1.16 M(+984.1%) |
| June 2009 | - | $14.00 K(+75.0%) | $107.00 K(-56.3%) |
| Mar 2009 | - | $8000.00(-61.9%) | $245.00 K(-33.8%) |
| Dec 2008 | $369.00 K(-10.4%) | $21.00 K(-67.2%) | $370.00 K(-23.1%) |
| Sept 2008 | - | $64.00 K(-57.9%) | $481.00 K(-10.6%) |
| June 2008 | - | $152.00 K(+14.3%) | $538.00 K(-1.5%) |
| Mar 2008 | - | $133.00 K(+0.8%) | $546.00 K(+32.2%) |
| Dec 2007 | $412.00 K(-92.4%) | $132.00 K(+9.1%) | $413.00 K(+47.0%) |
| Sept 2007 | - | $121.00 K(-24.4%) | $281.00 K(+75.6%) |
| June 2007 | - | $160.00 K(-88.9%) | $160.00 K(-97.0%) |
| Dec 2005 | $5.39 M(-0.2%) | $1.44 M(+8.0%) | $5.39 M(-0.7%) |
| Sept 2005 | - | $1.34 M(+7.0%) | $5.43 M(-2.2%) |
| June 2005 | - | $1.25 M(-8.1%) | $5.55 M(-0.6%) |
| Mar 2005 | - | $1.36 M(-8.2%) | $5.58 M(+3.3%) |
| Dec 2004 | $5.40 M(+11.5%) | $1.48 M(+1.6%) | $5.40 M(+2.3%) |
| Sept 2004 | - | $1.46 M(+13.6%) | $5.28 M(+3.7%) |
| June 2004 | - | $1.28 M(+8.8%) | $5.09 M(+3.4%) |
| Mar 2004 | - | $1.18 M(-13.1%) | $4.92 M(+1.5%) |
| Dec 2003 | $4.85 M(+3.8%) | $1.36 M(+7.1%) | $4.85 M(+11.9%) |
| Sept 2003 | - | $1.27 M(+13.5%) | $4.33 M(-1.7%) |
| June 2003 | - | $1.12 M(+1.0%) | $4.41 M(-2.9%) |
| Mar 2003 | - | $1.11 M(+31.5%) | $4.54 M(+3.5%) |
| Dec 2002 | $4.67 M | $841.00 K(-37.4%) | $4.38 M(+13.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2002 | - | $1.34 M(+7.5%) | $3.87 M(+10.7%) |
| June 2002 | - | $1.25 M(+31.2%) | $3.50 M(+7.7%) |
| Mar 2002 | - | $952.00 K(+192.6%) | $3.25 M(-0.6%) |
| Dec 2001 | $3.27 M(-3.0%) | $325.40 K(-66.4%) | $3.26 M(-14.5%) |
| Sept 2001 | - | $968.60 K(-3.2%) | $3.82 M(+2.2%) |
| June 2001 | - | $1.00 M(+3.0%) | $3.74 M(+3.6%) |
| Mar 2001 | - | $970.70 K(+10.3%) | $3.61 M(+7.1%) |
| Dec 2000 | $3.37 M(-28.4%) | $880.20 K(-0.7%) | $3.37 M(-2.2%) |
| Sept 2000 | - | $886.60 K(+2.0%) | $3.44 M(-2.1%) |
| June 2000 | - | $869.00 K(+19.0%) | $3.52 M(-52.2%) |
| Mar 2000 | - | $730.20 K(-23.5%) | $7.35 M(-35.7%) |
| Dec 1999 | $4.70 M(+51.6%) | $954.50 K(-0.7%) | $11.42 M(+195.6%) |
| Sept 1999 | - | $961.40 K(-79.5%) | $3.86 M(-50.5%) |
| June 1999 | - | $4.70 M(-2.1%) | $7.80 M(-4.9%) |
| Mar 1999 | - | $4.80 M(-172.7%) | $8.20 M(+2.5%) |
| Dec 1998 | $3.10 M(-82.0%) | -$6.60 M(-234.7%) | $8.00 M(-55.8%) |
| Sept 1998 | - | $4.90 M(-3.9%) | $18.10 M(+4.6%) |
| June 1998 | - | $5.10 M(+10.9%) | $17.30 M(+3.6%) |
| Mar 1998 | - | $4.60 M(+31.4%) | $16.70 M(-2.3%) |
| Dec 1997 | $17.20 M(-8.0%) | $3.50 M(-14.6%) | $17.10 M(-1.7%) |
| Sept 1997 | - | $4.10 M(-8.9%) | $17.40 M(-1.7%) |
| June 1997 | - | $4.50 M(-10.0%) | $17.70 M(-4.8%) |
| Mar 1997 | - | $5.00 M(+31.6%) | $18.60 M(-1.1%) |
| Dec 1996 | $18.70 M(+16.1%) | $3.80 M(-13.6%) | $18.80 M(+3.3%) |
| Sept 1996 | - | $4.40 M(-18.5%) | $18.20 M(+7.7%) |
| June 1996 | - | $5.40 M(+3.8%) | $16.90 M(+4.3%) |
| Mar 1996 | - | $5.20 M(+62.5%) | $16.20 M(+0.6%) |
| Dec 1995 | $16.10 M(+1.3%) | $3.20 M(+3.2%) | $16.10 M(+1.3%) |
| Sept 1995 | - | $3.10 M(-34.0%) | $15.90 M(-1.9%) |
| June 1995 | - | $4.70 M(-7.8%) | $16.20 M(+1.9%) |
| Mar 1995 | - | $5.10 M(+70.0%) | $15.90 M(0.0%) |
| Dec 1994 | $15.90 M(-20.1%) | $3.00 M(-11.8%) | $15.90 M(-10.2%) |
| Sept 1994 | - | $3.40 M(-22.7%) | $17.70 M(-3.8%) |
| June 1994 | - | $4.40 M(-13.7%) | $18.40 M(-3.7%) |
| Mar 1994 | - | $5.10 M(+6.3%) | $19.10 M(+15.8%) |
| Dec 1993 | $19.90 M(+172.6%) | $4.80 M(+17.1%) | $16.50 M(+17.0%) |
| Sept 1993 | - | $4.10 M(-19.6%) | $14.10 M(+17.5%) |
| June 1993 | - | $5.10 M(+104.0%) | $12.00 M(+31.9%) |
| Mar 1993 | - | $2.50 M(+4.2%) | $9.10 M(+24.7%) |
| Dec 1992 | $7.30 M(+160.7%) | $2.40 M(+20.0%) | $7.30 M(+37.7%) |
| Sept 1992 | - | $2.00 M(-9.1%) | $5.30 M(+39.5%) |
| June 1992 | - | $2.20 M(+214.3%) | $3.80 M(+22.6%) |
| Mar 1992 | - | $700.00 K(+75.0%) | $3.10 M(+10.7%) |
| Dec 1991 | $2.80 M(+16.7%) | $400.00 K(-20.0%) | $2.80 M(-9.7%) |
| Sept 1991 | - | $500.00 K(-66.7%) | $3.10 M(+3.3%) |
| June 1991 | - | $1.50 M(+275.0%) | $3.00 M(+30.4%) |
| Mar 1991 | - | $400.00 K(-42.9%) | $2.30 M(-8.0%) |
| Dec 1990 | $2.40 M(-14.3%) | $700.00 K(+75.0%) | $2.50 M(+4.2%) |
| Sept 1990 | - | $400.00 K(-50.0%) | $2.40 M(-4.0%) |
| June 1990 | - | $800.00 K(+33.3%) | $2.50 M(-16.7%) |
| Mar 1990 | - | $600.00 K(0.0%) | $3.00 M(+3.4%) |
| Dec 1989 | $2.80 M(+12.0%) | $600.00 K(+20.0%) | $2.90 M(+3.6%) |
| Sept 1989 | - | $500.00 K(-61.5%) | $2.80 M(-3.4%) |
| June 1989 | - | $1.30 M(+160.0%) | $2.90 M(+38.1%) |
| Mar 1989 | - | $500.00 K(0.0%) | $2.10 M(-16.0%) |
| Dec 1988 | $2.50 M(+47.1%) | $500.00 K(-16.7%) | $2.50 M(-7.4%) |
| Sept 1988 | - | $600.00 K(+20.0%) | $2.70 M(+12.5%) |
| June 1988 | - | $500.00 K(-44.4%) | $2.40 M(+4.3%) |
| Mar 1988 | - | $900.00 K(+28.6%) | $2.30 M(+35.3%) |
| Dec 1987 | $1.70 M | $700.00 K(+133.3%) | $1.70 M(+70.0%) |
| Sept 1987 | - | $300.00 K(-25.0%) | $1.00 M(+42.9%) |
| June 1987 | - | $400.00 K(+33.3%) | $700.00 K(+133.3%) |
| Mar 1987 | - | $300.00 K | $300.00 K |
FAQ
- What is Heron Therapeutics annual revenue?
- What is the all time high annual revenue for Heron Therapeutics?
- What is Heron Therapeutics annual revenue year-on-year change?
- What is Heron Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Heron Therapeutics?
- What is Heron Therapeutics quarterly revenue year-on-year change?
- What is Heron Therapeutics TTM revenue?
- What is the all time high TTM revenue for Heron Therapeutics?
- What is Heron Therapeutics TTM revenue year-on-year change?
What is Heron Therapeutics annual revenue?
The current annual revenue of HRTX is $127.04 M
What is the all time high annual revenue for Heron Therapeutics?
Heron Therapeutics all-time high annual revenue is $145.97 M
What is Heron Therapeutics annual revenue year-on-year change?
Over the past year, HRTX annual revenue has changed by +$19.37 M (+17.99%)
What is Heron Therapeutics quarterly revenue?
The current quarterly revenue of HRTX is $32.81 M
What is the all time high quarterly revenue for Heron Therapeutics?
Heron Therapeutics all-time high quarterly revenue is $42.62 M
What is Heron Therapeutics quarterly revenue year-on-year change?
Over the past year, HRTX quarterly revenue has changed by +$1.38 M (+4.38%)
What is Heron Therapeutics TTM revenue?
The current TTM revenue of HRTX is $137.74 M
What is the all time high TTM revenue for Heron Therapeutics?
Heron Therapeutics all-time high TTM revenue is $145.97 M
What is Heron Therapeutics TTM revenue year-on-year change?
Over the past year, HRTX TTM revenue has changed by +$14.90 M (+12.13%)